ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...
| Prif Awdur: | |
|---|---|
| Fformat: | Erthygl |
| Iaith: | English |
| Cyhoeddwyd: |
"Paediatrician" Publishers LLC
2008-08-01
|
| Cyfres: | Вопросы современной педиатрии |
| Mynediad Ar-lein: | https://vsp.spr-journal.ru/jour/article/view/1441 |
Search Result 1
ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
Cyhoeddwyd 2008-01-01
Cael y testun llawn
Erthygl